UCFA
EBS icon

United Capital Financial Advisors’s Emergent Biosolutions EBS Stock Holding History

United Capital Financial Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,522
Closed -$435K – 1201
2020
Q1 		$435K Buy
+7,522
New +$433K ﹤0.01% 866

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

United Capital Financial Advisors's EBS Position: Q2 2020 in Review

United Capital Financial Advisors sold out of Emergent Biosolutions (EBS) in Q2 2020, closing a stake of 7,522 shares — an estimated $435K sold.

United Capital Financial Advisors first reported a position in EBS in Q1 2020 and held it in 1 quarter. The position peaked at $435K in Q1 2020. 299 funds tracked by Wall St. Rank hold EBS as of Q2 2020.

  • United Capital Financial Advisors reported no remaining Emergent Biosolutions position as of Q2 2020 after selling out during the quarter.
  • United Capital Financial Advisors sold 7,522 Emergent Biosolutions shares in Q2 2020, an estimated $435K.
  • United Capital Financial Advisors first reported a position in Emergent Biosolutions in Q1 2020 and held it in 1 quarter.
  • United Capital Financial Advisors's Emergent Biosolutions position peaked at $435K in Q1 2020.
  • 299 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2020.

Based on United Capital Financial Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.